CD4+T/CD8+T cell infiltration and PD-L1 expression in resected specimens can be used to predict the progression and growth environment of patients' tumors to a certain extent, which is convenient for clinicians to predict treatment and medication in advance. Metastatic CRC has significant differences in tumor infiltration and MSI from nonmetastatic CRC.
Liu et al. (Thu,) studied this question.